Topical roflumilast for the treatment of psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topical roflumilast for the treatment of psoriasis

Published:2023-05-30 Issue:9 Volume:19 Page:1053-1062
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Drakos Anastasia¹,Vender Ron²³^ORCID,Torres Tiago⁴⁵^ORCID

Affiliation:

1. Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

2. Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, ON, Canada

3. Department of Medicine, McMaster University, Hamilton, ON, Canada

4. Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal

5. Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2023.2219897

Reference52 articles.

1. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

2. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

3. Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life

4. Long-term topical management of psoriasis: the road ahead

5. Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting next-generation PDE4 inhibitors in search of potential management of rheumatoid arthritis and psoriasis;Bioorganic Chemistry;2024-10

2. Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor;Indian Journal of Dermatology;2024-09-13

3. A comparison of the safety and efficacy of tapinarof and roflumilast topical therapies in the management of mild‐to‐moderate plaque psoriasis;Skin Research and Technology;2024-08-29

4. Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Clinical Drug Investigation;2024-08-22

5. Development and Optimization of Dipyridamole- and Roflumilast-Loaded Nanoemulsion and Nanoemulgel for Enhanced Skin Permeation: Formulation, Characterization, and In Vitro Assessment;Pharmaceuticals;2024-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3